{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:33:39Z","timestamp":1792589619193,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-KH135060"],"award-info":[{"award-number":["RS-2023-KH135060"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-KH135060"],"award-info":[{"award-number":["RS-2023-KH135060"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-KH135060"],"award-info":[{"award-number":["RS-2023-KH135060"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-KH135060"],"award-info":[{"award-number":["RS-2023-KH135060"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020206","name":"Korea Dementia Research Center","doi-asserted-by":"publisher","award":["RS-2021-KH112548"],"award-info":[{"award-number":["RS-2021-KH112548"]}],"id":[{"id":"10.13039\/100020206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020206","name":"Korea Dementia Research Center","doi-asserted-by":"publisher","award":["RS-2021-KH112548"],"award-info":[{"award-number":["RS-2021-KH112548"]}],"id":[{"id":"10.13039\/100020206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020206","name":"Korea Dementia Research Center","doi-asserted-by":"publisher","award":["RS-2021-KH112548"],"award-info":[{"award-number":["RS-2021-KH112548"]}],"id":[{"id":"10.13039\/100020206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012633","name":"INNOPOLIS Foundation","doi-asserted-by":"publisher","award":["RS-2024-00418133"],"award-info":[{"award-number":["RS-2024-00418133"]}],"id":[{"id":"10.13039\/501100012633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012633","name":"INNOPOLIS Foundation","doi-asserted-by":"publisher","award":["RS-2024-00418133"],"award-info":[{"award-number":["RS-2024-00418133"]}],"id":[{"id":"10.13039\/501100012633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012633","name":"INNOPOLIS Foundation","doi-asserted-by":"publisher","award":["RS-2024-00418133"],"award-info":[{"award-number":["RS-2024-00418133"]}],"id":[{"id":"10.13039\/501100012633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012633","name":"INNOPOLIS Foundation","doi-asserted-by":"publisher","award":["RS-2024-00418133"],"award-info":[{"award-number":["RS-2024-00418133"]}],"id":[{"id":"10.13039\/501100012633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012633","name":"INNOPOLIS Foundation","doi-asserted-by":"publisher","award":["RS-2024-00418133"],"award-info":[{"award-number":["RS-2024-00418133"]}],"id":[{"id":"10.13039\/501100012633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["RS-2024-00432516"],"award-info":[{"award-number":["RS-2024-00432516"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["RS-2024-00432516"],"award-info":[{"award-number":["RS-2024-00432516"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["RS-2024-00432516"],"award-info":[{"award-number":["RS-2024-00432516"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003661","name":"Korea Institute for Advancement of Technology","doi-asserted-by":"publisher","award":["RS-2024-00432516"],"award-info":[{"award-number":["RS-2024-00432516"]}],"id":[{"id":"10.13039\/501100003661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02412-1","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T02:39:31Z","timestamp":1747881571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Aducanumab delivery via focused ultrasound-induced transient blood\u2013brain barrier opening in vivo"],"prefix":"10.1038","volume":"15","author":[{"given":"Jaeyeong","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-ryul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2412_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.7150\/thno.21254","volume":"8","author":"X Dong","year":"2018","unstructured":"Dong, X. Current strategies for brain drug delivery. Theranostics 8, 1481\u20131493. https:\/\/doi.org\/10.7150\/thno.21254 (2018).","journal-title":"Theranostics"},{"key":"2412_CR2","doi-asserted-by":"publisher","unstructured":"Teleanu, R. I. et al. Current strategies to enhance delivery of drugs across the Blood-Brain barrier. Pharmaceutics 14 https:\/\/doi.org\/10.3390\/pharmaceutics14050987 (2022).","DOI":"10.3390\/pharmaceutics14050987"},{"key":"2412_CR3","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman, R. & Prat, A. The blood-brain barrier. Cold Spring Harb Perspect. Biol. 7, a020412. https:\/\/doi.org\/10.1101\/cshperspect.a020412 (2015).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"2412_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2045-8118-9-23","volume":"9","author":"AC Luissint","year":"2012","unstructured":"Luissint, A. C., Artus, C., Glacial, F., Ganeshamoorthy, K. & Couraud, P. O. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS. 9, 23. https:\/\/doi.org\/10.1186\/2045-8118-9-23 (2012).","journal-title":"Fluids Barriers CNS"},{"key":"2412_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry, H., Noorani, B. & Cucullo, L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 17, 69. https:\/\/doi.org\/10.1186\/s12987-020-00230-3 (2020).","journal-title":"Fluids Barriers CNS"},{"key":"2412_CR6","doi-asserted-by":"publisher","unstructured":"Banks, W. A. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 9 (Suppl 1). https:\/\/doi.org\/10.1186\/1471-2377-9-S1-S3 (2009).","DOI":"10.1186\/1471-2377-9-S1-S3"},{"key":"2412_CR7","doi-asserted-by":"publisher","unstructured":"Han, L. Modulation of the Blood-Brain barrier for drug delivery to brain. Pharmaceutics 13 https:\/\/doi.org\/10.3390\/pharmaceutics13122024 (2021).","DOI":"10.3390\/pharmaceutics13122024"},{"key":"2412_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fphar.2019.00086","volume":"10","author":"KT Chen","year":"2019","unstructured":"Chen, K. T., Wei, K. C. & Liu, H. L. Theranostic strategy of focused ultrasound induced Blood-Brain barrier opening for CNS disease treatment. Front. Pharmacol. 10, 86. https:\/\/doi.org\/10.3389\/fphar.2019.00086 (2019).","journal-title":"Front. Pharmacol."},{"key":"2412_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17425247.2024.2438188","volume":"22","author":"CF Chuang","year":"2025","unstructured":"Chuang, C. F., Phan, T. N., Fan, C. H., Le, V., Yeh, C. K. & T. T. & Advancements in ultrasound-mediated drug delivery for central nervous system disorders. Expert Opin. Drug Deliv. 22, 15\u201330. https:\/\/doi.org\/10.1080\/17425247.2024.2438188 (2025).","journal-title":"Expert Opin. Drug Deliv."},{"key":"2412_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1586\/14737175.2015.1028369","volume":"15","author":"A Burgess","year":"2015","unstructured":"Burgess, A., Shah, K., Hough, O. & Hynynen, K. Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev. Neurother. 15, 477\u2013491. https:\/\/doi.org\/10.1586\/14737175.2015.1028369 (2015).","journal-title":"Expert Rev. Neurother."},{"key":"2412_CR11","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ultrasmedbio.2007.11.009","volume":"34","author":"N McDannold","year":"2008","unstructured":"McDannold, N., Vykhodtseva, N. & Hynynen, K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound. Med. Biol. 34, 930\u2013937 (2008).","journal-title":"Ultrasound. Med. Biol."},{"key":"2412_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/jcbfm.2010.155","volume":"31","author":"JJ Choi","year":"2011","unstructured":"Choi, J. J. et al. Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies. J. Cereb. Blood Flow. Metab. 31, 725\u2013737. https:\/\/doi.org\/10.1038\/jcbfm.2010.155 (2011).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"2412_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1021\/cn9000445","volume":"1","author":"R Chopra","year":"2010","unstructured":"Chopra, R., Vykhodtseva, N. & Hynynen, K. Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures. ACS Chem. Neurosci. 1, 391\u2013398. https:\/\/doi.org\/10.1021\/cn9000445 (2010).","journal-title":"ACS Chem. Neurosci."},{"key":"2412_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mrm.22848","volume":"66","author":"F Vlachos","year":"2011","unstructured":"Vlachos, F., Tung, Y. S. & Konofagou, E. Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI. Magn. Reson. Med. 66, 821\u2013830. https:\/\/doi.org\/10.1002\/mrm.22848 (2011).","journal-title":"Magn. Reson. Med."},{"key":"2412_CR15","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/2017.11.FOCUS17627","volume":"44","author":"J Shin","year":"2018","unstructured":"Shin, J. et al. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters. Neurosurg. Focus. 44, E15. https:\/\/doi.org\/10.3171\/2017.11.FOCUS17627 (2018).","journal-title":"Neurosurg. Focus"},{"key":"2412_CR16","doi-asserted-by":"publisher","first-page":"20180601","DOI":"10.1259\/bjr.20180601","volume":"92","author":"RM Jones","year":"2019","unstructured":"Jones, R. M. & Hynynen, K. Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability. Br. J. Radiol. 92, 20180601. https:\/\/doi.org\/10.1259\/bjr.20180601 (2019).","journal-title":"Br. J. Radiol."},{"key":"2412_CR17","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","volume":"8","author":"JW Arndt","year":"2018","unstructured":"Arndt, J. W. et al. Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-beta. Sci. Rep. 8, 6412. https:\/\/doi.org\/10.1038\/s41598-018-24501-0 (2018).","journal-title":"Sci. Rep."},{"key":"2412_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356. https:\/\/doi.org\/10.1038\/nature19323 (2016).","journal-title":"Nature"},{"key":"2412_CR19","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","volume":"181","author":"B Dunn","year":"2021","unstructured":"Dunn, B., Stein, P. & Cavazzoni, P. Approval of aducanumab for alzheimer Disease-The FDA\u2019s perspective. JAMA Intern. Med. 181, 1276\u20131278. https:\/\/doi.org\/10.1001\/jamainternmed.2021.4607 (2021).","journal-title":"JAMA Intern. Med."},{"key":"2412_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S1474-4422(19)30480-6","volume":"19","author":"L Schneider","year":"2020","unstructured":"Schneider, L. A resurrection of aducanumab for Alzheimer\u2019s disease. Lancet Neurol. 19, 111\u2013112. https:\/\/doi.org\/10.1016\/S1474-4422(19)30480-6 (2020).","journal-title":"Lancet Neurol."},{"key":"2412_CR21","doi-asserted-by":"publisher","unstructured":"Tampi, R. R., Forester, B. P. & Agronin, M. Aducanumab: evidence from clinical trial data and controversies. Drugs Context. 10 https:\/\/doi.org\/10.7573\/dic.2021-7-3 (2021).","DOI":"10.7573\/dic.2021-7-3"},{"key":"2412_CR22","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2021.3854","volume":"325","author":"GC Alexander","year":"2021","unstructured":"Alexander, G. C., Emerson, S. & Kesselheim, A. S. Evaluation of aducanumab for alzheimer disease: scientific evidence and regulatory review involving efficacy, safety, and futility. JAMA 325, 1717\u20131718. https:\/\/doi.org\/10.1001\/jama.2021.3854 (2021).","journal-title":"JAMA"},{"key":"2412_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","volume":"17","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S., Jones, D. T. & Greicius, M. D. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by biogen, December 2019. Alzheimers Dement. 17, 696\u2013701. https:\/\/doi.org\/10.1002\/alz.12213 (2021).","journal-title":"Alzheimers Dement."},{"key":"2412_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40035-022-00333-x","volume":"11","author":"C Kong","year":"2022","unstructured":"Kong, C. et al. Enhanced delivery of a low dose of aducanumab via FUS in 5xFAD mice, an AD model. Transl Neurodegener. 11, 57. https:\/\/doi.org\/10.1186\/s40035-022-00333-x (2022).","journal-title":"Transl Neurodegener"},{"key":"2412_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13195-021-00809-4","volume":"13","author":"G Leinenga","year":"2021","unstructured":"Leinenga, G., Koh, W. K. & Gotz, J. A comparative study of the effects of aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of alzheimer disease. Alzheimers Res. Ther. 13, 76. https:\/\/doi.org\/10.1186\/s13195-021-00809-4 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"2412_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12987-022-00402-3","volume":"19","author":"HJ Choi","year":"2022","unstructured":"Choi, H. J. et al. The new insight into the inflammatory response following focused ultrasound-mediated blood-brain barrier disruption. Fluids Barriers CNS. 19, 103. https:\/\/doi.org\/10.1186\/s12987-022-00402-3 (2022).","journal-title":"Fluids Barriers CNS"},{"key":"2412_CR27","doi-asserted-by":"publisher","unstructured":"Choi, H. J. et al. Methylene blue delivery mediated by focused Ultrasound-Induced Blood-Brain barrier disruption reduces neural damage and Amyloid-Beta plaques by AQP-4 upregulation. Biomedicines 10 https:\/\/doi.org\/10.3390\/biomedicines10123191 (2022).","DOI":"10.3390\/biomedicines10123191"},{"key":"2412_CR28","doi-asserted-by":"publisher","first-page":"685977","DOI":"10.3389\/fnins.2021.685977","volume":"15","author":"M Han","year":"2021","unstructured":"Han, M., Seo, H., Choi, H., Lee, E. H. & Park, J. Localized modification of water molecule transport after focused Ultrasound-Induced Blood-Brain barrier disruption in rat brain. Front. Neurosci. 15, 685977. https:\/\/doi.org\/10.3389\/fnins.2021.685977 (2021).","journal-title":"Front. Neurosci."},{"key":"2412_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2019.10.044","volume":"315","author":"B Jung","year":"2019","unstructured":"Jung, B., Huh, H., Lee, E. H., Han, M. & Park, J. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain. J. Control Release. 315, 55\u201364. https:\/\/doi.org\/10.1016\/j.jconrel.2019.10.044 (2019).","journal-title":"J. Control Release"},{"key":"2412_CR30","doi-asserted-by":"publisher","first-page":"21534","DOI":"10.1038\/s41598-020-78657-9","volume":"10","author":"D McMahon","year":"2020","unstructured":"McMahon, D., Lassus, A., Gaud, E., Jeannot, V. & Hynynen, K. Microbubble formulation influences inflammatory response to focused ultrasound exposure in the brain. Sci. Rep. 10, 21534. https:\/\/doi.org\/10.1038\/s41598-020-78657-9 (2020).","journal-title":"Sci. Rep."},{"key":"2412_CR31","doi-asserted-by":"publisher","first-page":"33264","DOI":"10.1038\/srep33264","volume":"6","author":"PC Chu","year":"2016","unstructured":"Chu, P. C. et al. Focused Ultrasound-Induced Blood-Brain barrier opening: association with mechanical index and cavitation index analyzed by dynamic Contrast-Enhanced Magnetic-Resonance imaging. Sci. Rep. 6, 33264. https:\/\/doi.org\/10.1038\/srep33264 (2016).","journal-title":"Sci. Rep."},{"key":"2412_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/1471-2105-14-316","volume":"14","author":"JE Ortuno","year":"2013","unstructured":"Ortuno, J. E. et al. DCE@urLAB: a dynamic contrast-enhanced MRI Pharmacokinetic analysis tool for preclinical data. BMC Bioinform. 14, 316. https:\/\/doi.org\/10.1186\/1471-2105-14-316 (2013).","journal-title":"BMC Bioinform."},{"key":"2412_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jconrel.2012.06.012","volume":"162","author":"J Park","year":"2012","unstructured":"Park, J., Zhang, Y., Vykhodtseva, N., Jolesz, F. A. & McDannold, N. J. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J. Control Release. 162, 134\u2013142. https:\/\/doi.org\/10.1016\/j.jconrel.2012.06.012 (2012).","journal-title":"J. Control Release"},{"key":"2412_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2016.10.011","volume":"250","author":"J Park","year":"2017","unstructured":"Park, J., Aryal, M., Vykhodtseva, N., Zhang, Y. Z. & McDannold, N. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption. J. Control Release. 250, 77\u201385. https:\/\/doi.org\/10.1016\/j.jconrel.2016.10.011 (2017).","journal-title":"J. Control Release"},{"key":"2412_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to imageJ: 25 years of image analysis. Nat. Methods. 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"2412_CR36","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","volume":"26","author":"H Sonoda","year":"2018","unstructured":"Sonoda, H. et al. A Blood-Brain-Barrier-Penetrating Anti-human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II. Molecular therapy. J. Am. Soc. Gene Therapy. 26, 1366\u20131374. https:\/\/doi.org\/10.1016\/j.ymthe.2018.02.032 (2018).","journal-title":"J. Am. Soc. Gene Therapy"},{"key":"2412_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.074","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Huber, C. C. & Wang, H. Disrupted blood-brain barrier in 5xFAD mouse model of Alzheimer\u2019s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. Biochem. Biophys. Res. Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.074 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2412_CR38","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne, A., Zhao, Z. & Zlokovic, B. V. Alzheimer\u2019s disease: A matter of blood-brain barrier dysfunction? J. Exp. Med. 214, 3151\u20133169. https:\/\/doi.org\/10.1084\/jem.20171406 (2017).","journal-title":"J. Exp. Med."},{"key":"2412_CR39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1056\/NEJMoa1600159","volume":"375","author":"WJ Elias","year":"2016","unstructured":"Elias, W. J. et al. A randomized trial of focused ultrasound thalamotomy for essential tremor. N Engl. J. Med. 375, 730\u2013739. https:\/\/doi.org\/10.1056\/NEJMoa1600159 (2016).","journal-title":"N Engl. J. Med."},{"key":"2412_CR40","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1038\/s41467-018-04529-6","volume":"9","author":"N Lipsman","year":"2018","unstructured":"Lipsman, N. et al. Blood-brain barrier opening in Alzheimer\u2019s disease using MR-guided focused ultrasound. Nat. Commun. 9, 2336. https:\/\/doi.org\/10.1038\/s41467-018-04529-6 (2018).","journal-title":"Nat. Commun."},{"key":"2412_CR41","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/mds.26997","volume":"32","author":"VK Ravikumar","year":"2017","unstructured":"Ravikumar, V. K. et al. Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor. Mov. Disord. 32, 1165\u20131173. https:\/\/doi.org\/10.1002\/mds.26997 (2017).","journal-title":"Mov. Disord"},{"key":"2412_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10143-019-01216-y","volume":"44","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Safety and efficacy of magnetic resonance imaging-guided focused ultrasound neurosurgery for Parkinson\u2019s disease: a systematic review. Neurosurg. Rev. 44, 115\u2013127. https:\/\/doi.org\/10.1007\/s10143-019-01216-y (2021).","journal-title":"Neurosurg. Rev."},{"key":"2412_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1148\/radiol.11111417","volume":"263","author":"MA O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly, M. A. & Hynynen, K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 263, 96\u2013106. https:\/\/doi.org\/10.1148\/radiol.11111417 (2012).","journal-title":"Radiology"},{"key":"2412_CR44","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1109\/tuffc.2013.6644731","volume":"60","author":"G Samiotaki","year":"2013","unstructured":"Samiotaki, G. & Konofagou, E. E. Dependence of the reversibility of focused- ultrasound-induced blood-brain barrier opening on pressure and pulse length in vivo. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 60, 2257\u20132265. https:\/\/doi.org\/10.1109\/tuffc.2013.6644731 (2013).","journal-title":"IEEE Trans. Ultrason. Ferroelectr. Freq. Control"},{"key":"2412_CR45","doi-asserted-by":"publisher","unstructured":"Bayon-Cordero, L., Alkorta, I. & Arana, L. Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials (Basel). 9 https:\/\/doi.org\/10.3390\/nano9030474 (2019).","DOI":"10.3390\/nano9030474"},{"key":"2412_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1148\/radiol.10090699","volume":"255","author":"HL Liu","year":"2010","unstructured":"Liu, H. L. et al. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255, 415\u2013425. https:\/\/doi.org\/10.1148\/radiol.10090699 (2010).","journal-title":"Radiology"},{"key":"2412_CR47","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3389\/fnins.2018.01019","volume":"12","author":"VM Pulgar","year":"2018","unstructured":"Pulgar, V. M. Transcytosis to cross the blood brain barrier, new advancements and challenges. Front. Neurosci. 12, 1019. https:\/\/doi.org\/10.3389\/fnins.2018.01019 (2018).","journal-title":"Front. Neurosci."},{"key":"2412_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1570159X11311020006","volume":"11","author":"LL Zou","year":"2013","unstructured":"Zou, L. L., Ma, J. L., Wang, T., Yang, T. B. & Liu, C. B. Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system. Curr. Neuropharmacol. 11, 197\u2013208. https:\/\/doi.org\/10.2174\/1570159X11311020006 (2013).","journal-title":"Curr. Neuropharmacol."},{"key":"2412_CR49","doi-asserted-by":"publisher","first-page":"e2001375","DOI":"10.1002\/adhm.202001375","volume":"10","author":"M Ayer","year":"2021","unstructured":"Ayer, M. et al. T Cell-Mediated transport of polymer nanoparticles across the Blood-Brain barrier. Adv. Healthc. Mater. 10, e2001375. https:\/\/doi.org\/10.1002\/adhm.202001375 (2021).","journal-title":"Adv. Healthc. Mater."},{"key":"2412_CR50","doi-asserted-by":"publisher","first-page":"101496","DOI":"10.1016\/j.arr.2021.101496","volume":"72","author":"D Jeremic","year":"2021","unstructured":"Jeremic, D., Jimenez-Diaz, L. & Navarro-Lopez, J. D. Past, present and future of therapeutic strategies against amyloid-beta peptides in Alzheimer\u2019s disease: a systematic review. Ageing Res. Rev. 72, 101496. https:\/\/doi.org\/10.1016\/j.arr.2021.101496 (2021).","journal-title":"Ageing Res. Rev."},{"key":"2412_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1172\/JCI18162","volume":"112","author":"JL Eriksen","year":"2003","unstructured":"Eriksen, J. L. et al. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J. Clin. Invest. 112, 440\u2013449. https:\/\/doi.org\/10.1172\/JCI18162 (2003).","journal-title":"J. Clin. Invest."},{"key":"2412_CR52","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nature07055","volume":"453","author":"TL Kukar","year":"2008","unstructured":"Kukar, T. L. et al. Substrate-targeting gamma-secretase modulators. Nature 453, 925\u2013929. https:\/\/doi.org\/10.1038\/nature07055 (2008).","journal-title":"Nature"},{"key":"2412_CR53","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1001\/jama.2009.1866","volume":"302","author":"RC Green","year":"2009","unstructured":"Green, R. C. et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild alzheimer disease: a randomized controlled trial. JAMA 302, 2557\u20132564. https:\/\/doi.org\/10.1001\/jama.2009.1866 (2009).","journal-title":"JAMA"},{"key":"2412_CR54","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1523\/JNEUROSCI.4672-12.2013","volume":"33","author":"H Davtyan","year":"2013","unstructured":"Davtyan, H. et al. Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer\u2019s disease: Prelude to a clinical trial. J. Neurosci. 33, 4923\u20134934. https:\/\/doi.org\/10.1523\/JNEUROSCI.4672-12.2013 (2013).","journal-title":"J. Neurosci."},{"key":"2412_CR55","doi-asserted-by":"publisher","first-page":"e12090","DOI":"10.1002\/trc2.12090","volume":"6","author":"S Weninger","year":"2020","unstructured":"Weninger, S. et al. Active immunotherapy and alternative therapeutic modalities for Alzheimer\u2019s disease. Alzheimers Dement. (N Y). 6, e12090. https:\/\/doi.org\/10.1002\/trc2.12090 (2020).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"2412_CR56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","volume":"3","author":"CY Wang","year":"2017","unstructured":"Wang, C. Y. et al. UB-311, a novel UBITh((R)) amyloid beta peptide vaccine for mild Alzheimer\u2019s disease. Alzheimers Dement. (N Y). 3, 262\u2013272. https:\/\/doi.org\/10.1016\/j.trci.2017.03.005 (2017).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"2412_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, H., Li, R., Sterling, K. & Song, W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal. Transduct. Target. Therapy. 8, 248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"2412_CR58","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M. A. et al. Donanemab in early Alzheimer\u2019s disease. N Engl. J. Med. 384, 1691\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa2100708 (2021).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02412-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T15:01:39Z","timestamp":1748271699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2412"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02412-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were approved by the Animal Experiment Ethics Committee of Daegu\u2013Gyeongbuk Medical Innovation Foundation (IACUC approval number: KMEDI-22012601-00) and all procedures were conducted in accordance with the guideline. Also, the study was carried out in compliance with the ARRIVE (Animal research: reporting of in vivo experiments) guidelines (\n                      \n                      ) and all efforts were made to minimize a number of preclinical animals and their pain. Detailed steps of anesthesia to minimize their pain are described in a section of\n                      Materials and Methods\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17742"}}